As a trailblazer in Parkinson’s disease research, The Michael J. Fox Foundation (MJFF) collaborated with Quest Diagnostics, using our comprehensive data set and patient engagement services to identify additional potentially qualified participants for its landmark study, the Parkinson’s Progression Markers Initiative (PPMI).
Download and read the case study.
Please remember that email, including this web form, is not a secure method of communication. Do not submit personal information, including user names and passwords, social security numbers, or personal health information through this form.
Your Privacy Choices
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.
